Literature DB >> 2214548

Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy.

J W Coburn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2214548

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  7 in total

1.  Intraperitoneal Calcitriol for Treatment of Severe Hyperparathyroidism in Children with Chronic Kidney Disease: A Therapy Forgotten.

Authors:  Rahul Chanchlani; Susan Ackerman; Elizabeth Piva; Elizabeth Harvey
Journal:  Perit Dial Int       Date:  2016 11-12       Impact factor: 1.756

2.  Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism.

Authors:  Esra Baskin; Seza Ozen; Musturay Karçaaltincaba; Nesrin Besbas; Umit Saatci; Ali Düzova; Pinar Isik Agras; Mithat Haliloglu; Aysin Bakkaloglu
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

3.  Intramuscular calcitriol for uraemic children with severe hyperparathyroidism and hypercalcaemia.

Authors:  A Claris-Appiani; G L Ardissino; M C Tischer; A Bettinelli; A S Tirelli; V Daccò; G Castiglioni; F Pecchio; M Cunazza; B M Assael
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

Review 4.  New Vitamin D analogues for osteodystrophy in chronic kidney disease.

Authors:  John Cunningham
Journal:  Pediatr Nephrol       Date:  2004-05-13       Impact factor: 3.714

5.  Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease.

Authors:  Christopher L Newman; Nannan Tian; Max A Hammond; Joseph M Wallace; Drew M Brown; Neal X Chen; Sharon M Moe; Matthew R Allen
Journal:  Am J Nephrol       Date:  2016-02-17       Impact factor: 3.754

6.  Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue.

Authors:  Y Tominaga; Y Tanaka; K Sato; M Numano; K Uchida; U Falkmer; L Grimelius; H Johansson; H Takagi
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

7.  Comparison of oral and intravenous alfacalcidol in chronic hemodialysis patients.

Authors:  Myriam Lessard; Denis Ouimet; Martine Leblanc; Annie-Claire Nadeau-Fredette; Robert Bell; Jean-Philippe Lafrance; Vincent Pichette; Michel Vallée
Journal:  BMC Nephrol       Date:  2014-02-04       Impact factor: 2.388
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.